Original-Research: HBM Healthcare Investments AG (von Edison Investment Research Limited):

Original-Research: HBM Healthcare Investments AG - von Edison Investment Research Limited

Einstufung von Edison Investment Research Limited zu HBM Healthcare Investments AG

Unternehmen: HBM Healthcare Investments AG
ISIN: CH0012627250

Anlass der Studie:
Letzte Ratingänderung:
Analyst: Sarah Godfrey

London, UK, 2 March 2016
Edison initiates coverage on HBM Healthcare Investments

Edison Investment Research, a leading international investment research
firm, announces the initiation of full coverage of HBM Healthcare
Investments

Highlights of the analysis on HBM Healthcare Investments by Edison's
investment trust analysts Sarah Godfrey and Andrew Mitchell are as follows:

HBM Healthcare Investments (HBMN) is a Swiss investment company that
invests in healthcare companies globally. Its portfolio is spread across
private companies, private equity funds and public holdings, many of which
began in the private portfolio. After a buoyant IPO cycle it currently has
a relatively low proportion invested in private companies (14% at 31
December versus an average since inception in 2001 of 35.6%), but this is
set to rise, with $17.5m already committed to two new private investments
so far in 2016. HBMN invests broadly across healthcare (diversified by
sector, geography and company size) rather than concentrating on the
recently more volatile area of biotechnology. It has outperformed the MSCI
World Health Care Index over one and three years. Each year 5-8% of NAV is
expected to be returned to shareholders through a combination of share
buybacks and capital distributions (current yield of 5.6%).

HBM Healthcare Investments (previously HBM BioVentures, renamed in 2012)
aims to generate long-term gains through investment in private and public
companies in the human medicine, biotech, medtech and diagnostics sectors,
and related areas. It invests worldwide, predominantly in private
companies, either directly or through funds, and many of its publicly
listed holdings began as private equity investments.
Click here to view the full report

All reports published by Edison are available to download free of charge
from its website:
www.edisoninvestmentresearch.com

About Edison: We are an international equity advisory firm. We enable our
client companies to achieve their capital market objectives. The team is
made up of more than 80 analysts and investment professionals with many
decades of experience. Our extensive company knowledge and industry
expertise spans 10 business sectors and more than 700 listed companies
globally. We give our corporate clients and investors privileged insight
into global investment trends. Our distribution capability is key to
ensuring that a global investor audience can access our investment
knowledge. Edison is authorised and regulated by the Financial Conduct
Authority.

Edison is not an adviser or broker-dealer and does not provide investment
advice. Edison's reports are not solicitations to buy or sell any
securities.

Contact details: Learn more at www.edisongroup.com and connect with Edison
on:




LinkedIn www.linkedin.com/company/edison-investment-research

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv





London
+44 (0)20 3077 5700
280 High Holborn
London,
WC1V 7EE
United Kingdom

New York
+1 646 653 7026
245 Park Avenue, 39th Floor
New York, NY 10167
US

Sydney
+61 (0)2 9258 1161
Level 25 Aurora Place
88 Philip Street
Sydney NSW 2000
Australia

Frankfurt
+49 (0)69 78 8076 960
Schumannstrasse
34b
60325 Frankfurt
Germany

Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/13581.pdf
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.edisoninvestmentresearch.com.

Kontakt für Rückfragen

-------------------übermittelt durch die EQS Group AG.-------------------


Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw.
Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung
oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.